Debt-to-equity of Altimmune, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Altimmune, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Altimmune, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 15%, a 47% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Altimmune, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 15% +5% +47% 30 Sep 2025
Q2 2025 13% +3% +29% 30 Jun 2025
Q1 2025 12% +3% +29% 31 Mar 2025
Q4 2024 11% +1% +15% 31 Dec 2024
Q3 2024 10% -1% -5% 30 Sep 2024
Q2 2024 10% 0% -2.7% 30 Jun 2024
Q1 2024 9% -1% -8.6% 31 Mar 2024
Q4 2023 10% 0% -1.9% 31 Dec 2023
Q3 2023 11% +1% +12% 30 Sep 2023
Q2 2023 11% 0% -0.19% 30 Jun 2023
Q1 2023 10% 0% +0.99% 31 Mar 2023
Q4 2022 10% +1% +12% 31 Dec 2022
Q3 2022 10% +1% +11% 30 Sep 2022
Q2 2022 11% +1% +12% 30 Jun 2022
Q1 2022 10% -2% -19% 31 Mar 2022
Q4 2021 9% -7% -44% 31 Dec 2021
Q3 2021 9% -12% -58% 30 Sep 2021
Q2 2021 9% -14% -60% 30 Jun 2021
Q1 2021 12% -5% -29% 31 Mar 2021
Q4 2020 16% +3% +24% 31 Dec 2020
Q3 2020 21% +9% +78% 30 Sep 2020
Q2 2020 24% +8% +52% 30 Jun 2020
Q1 2020 17% -5% -23% 31 Mar 2020
Q4 2019 13% -17% -57% 31 Dec 2019
Q3 2019 12% -25% -68% 30 Sep 2019
Q2 2019 15% -22% -59% 30 Jun 2019
Q1 2019 23% -7% -24% 31 Mar 2019
Q4 2018 30% +5% +19% 31 Dec 2018
Q3 2018 37% +15% +68% 30 Sep 2018
Q2 2018 38% +27% +268% 30 Jun 2018
Q1 2018 30% +22% +295% 31 Mar 2018
Q4 2017 25% +17% +209% 31 Dec 2017
Q3 2017 22% +16% +241% 30 Sep 2017
Q2 2017 10% -3% -22% 30 Jun 2017
Q1 2017 8% -7% -48% 31 Mar 2017
Q4 2016 8% -8% -50% 31 Dec 2016
Q3 2016 6% -16% -71% 30 Sep 2016
Q2 2016 13% -12% -47% 30 Jun 2016
Q1 2016 15% -13% -48% 31 Mar 2016
Q4 2015 16% -19% -53% 31 Dec 2015
Q3 2015 22% -35% -61% 30 Sep 2015
Q2 2015 25% -53% -68% 30 Jun 2015
Q1 2015 28% -63% -69% 31 Mar 2015
Q4 2014 35% -67% -66% 31 Dec 2014
Q3 2014 57% -38% -40% 30 Sep 2014
Q2 2014 78% -18% -19% 30 Jun 2014
Q1 2014 91% -2% -2.2% 31 Mar 2014
Q4 2013 101% +18% +21% 31 Dec 2013
Q3 2013 95% +25% +35% 30 Sep 2013
Q2 2013 96% +34% +56% 30 Jun 2013
Q1 2013 93% +29% +45% 31 Mar 2013
Q4 2012 84% 31 Dec 2012
Q3 2012 70% 30 Sep 2012
Q2 2012 61% 30 Jun 2012
Q1 2012 64% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.